Navigation Links
Investigators from Children's Hospital LA honored
Date:12/7/2010

LOS ANGELES (December 7, 2010) Three investigators from The Saban Research Institute of Children's Hospital Los Angeles have been elected into the prestigious Society for Pediatric Research. Their election to this Society represents peer recognition of their research achievements in pediatrics.

The Society for Pediatric Research exists to foster the research and career development of investigators engaged in creating new knowledge that advances the health and well‐being of young people. Membership is by election only.

Steven Mittelman, MD, PhD, conducts his research at the Center for Endocrinology, Diabetes and Metabolism at Children's Hospital Los Angeles, and is an assistant professor of Pediatrics, Physiology, and Biophysics at the Keck School of Medicine of the University of Southern California.

"Being overweight impairs our ability to treat a patient's leukemia, the most common cancer occurring in children," explains Dr. Mittelman. "We've found that fat cells secrete chemical messengers that cause leukemia cells to migrate into the fat. Fat cells also secrete factors that protect leukemia cells from chemotherapy, making the disease more difficult to treat."

Leo Mascarenhas, MD, MS, is director of the Clinical Trials Office in the Children's Center for Cancer and Blood Diseases and Principal Investigator for the National Cancer Institute funded Children's Oncology Group grant at Children's Hospital Los Angeles. He is an associate professor of Clinical Pediatrics at the Keck School of Medicine of the University of Southern California.

"Childhood cancer is the leading cause of disease-related death in pediatrics in the United States," says Dr. Mascarenhas whose research focuses on developmental therapeutics for patients with bone and soft tissue sarcomas. "Despite the remarkable progress made in the treatment of childhood cancer in the last four decades, improved therapies are still needed for our patients with a poor prognosis and less toxic therapies for those destined to survive. This can be accomplished only through basic, translational and clinical research."

The lab overseen by Sebastien Bouret, PhD, is part of the Neuroscience program at The Saban Research Institute of Children's Hospital. He is an assistant professor of Pediatrics at the Keck School of Medicine of the University of Southern California.

"One theory explaining obesity is called perinatal programming," said Dr. Bouret. "Perinatal programming refers to the effect of specific events, that occur during gestation and soon after birth, on lifelong health. Nutrition during pregnancy appears to have an important impact on obesity, with both maternal obesity and maternal malnutrition increasing the incidence of obesity and type 2 diabetes in babies born to these mothers."

Dr. Brent Polk, director of The Saban Research Institute and chair of the Department of Pediatrics said, "On behalf of the Department of Pediatrics and The Saban Research Institute, I congratulate Drs. Mittelman, Mascarenhas and Bouret on this important recognition of their respective contributions to pediatric oncology and obesity, two devastating conditions affecting children today. Their acknowledgement, by membership in the Society for Pediatric Research, also underlines the quality of overall research we are doing in pediatrics at Children's Hospital Los Angeles and at the Keck School of Medicine of the University of Southern California."


'/>"/>

Contact: Ellin Kavanagh
ekavanagh@chla.usc.edu
323-361-8505
Children's Hospital Los Angeles
Source:Eurekalert

Related medicine news :

1. Investigators examine colorectal cancer screening methods among diverse populations
2. UT Southwestern investigators perform head-to-head comparison of incontinence treatments
3. Damon Runyon Cancer Research Foundation awards $3.1M to 8 top young clinical investigators
4. Investigators identify gene associated with kidney disease in African-American population
5. SWOG names 5 cancer researchers outstanding Young Investigators
6. NCH investigators receive grant to distinguish bacterial infections from viral infections in infants
7. Parents Want Electronic Access to Their Childrens Docs: Survey
8. Researcher at Childrens Hospital LA discovers way to overcome radiation resistance in leukemia
9. The private sale of drugs in public hospitals
10. Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007
11. Bariatricfurnishings.com Launches Unique Eco-friendly Seating for Health Care, Hospitality, Assisted Living Centers, and Home Use at Competitive Prices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... Based on ... safety and efficacy of HBOT in treating and helping to heal addictions and ... research showing the similarities of the wounds to the brain from traumatic brain ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... healthcare industry, made the 2017 Inc. 5000 with a three-year sales growth ... nation’s fastest-growing private companies and comprises the most comprehensive look at America’s independent ...
(Date:8/23/2017)... ... 2017 , ... MobilityWorks ®, the nation's largest retailer ... Inc. 500|5000, an exclusive ranking of America’s fastest-growing private companies. MobilityWorks (aka WMK) ... the twelfth year that the company has been included on the list. , ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... the American Academy of Orthopaedic Surgeons , points out that therapeutic modalities ... from pain or injury. According to the report, a wider scope of physical ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... Aug. 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2017. The ... or about October 27, 2017 to stockholders of record as ... declarations of dividends are subject to approval of the Board ...
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
Breaking Medicine Technology: